June 30th Pre-Market Brief

Best quarter since 2020. So why is the Fed the problem?

Author

J.L. Bernstein
June 30, 2026

Good Morning

Quarter's a wrap, and what a stretch it's been. S&P put up 14% and the Nasdaq nearly 20%, best qtr since 2020, and that's with a war, an oil scare, and a tech selloff all crammed into three months. Markets just kept climbing over it. Futures are a touch red this AM, but honestly, things are looking up outside of this general AI skepticism.

Let’s dig in…

Today's Big Picture

Small Caps Are Winning On A Bet
The Russell is up 21% this year, nearly triple the S&P, its best first half since 1991. Most people are calling it a healthy move out of tech into smaller, safer names. It isn't: chips and chip-gear make up 16 of its 50 top performers, several up more than 400%, so this is the same AI bet in smaller clothes. And these companies borrow at rates that climb when the Fed does, so BofA figures each hike shaves about 2% off their profits, which makes the rally everyone calls safe the most rate-exposed one out there.

The Market Is Punishing Its Best Companies
Tech closed its best quarter since 2020, but the gains were not handed out evenly. Chipmakers had their best quarter on record while Microsoft just had its worst month since 2000. The strange part is who got hit: the names with the strongest businesses and the biggest cash piles, punished for spending that cash on AI. Investors will pay up for the hardware today, but they want proof the software spending pays off before they reward it.

The Dollar Is Doing The Fed's Job
A quarter this strong usually means the Fed is about to cut rates. This time it's the opposite, with traders now betting on three hikes after expecting cuts just months ago. The yen fell to a 40-year low and the dollar keeps climbing, both signs that money is bracing for rates to stay high. A rising dollar quietly pulls cash out of stocks, so if the Fed confirms the harder line this week, this calm does not last.

P.S. The Market does’’t reward yesterday's winners forever.

As the Magnificent 7 mature, the next generation of leaders begins to emerge - often quietly, before the crowd catches on.

Today’s Sponsor

The next A.I. boom could create massive winners just like the 1990s tech surge.

We identified 7 small tech companies positioned to benefit from the next phase of A.I. growth.

Stock Spotlight (pre-market)

AeroVironment $AVAV ( ▲ 0.76% )  

Up sharply premarket on an earnings and revenue beat, $1.84 against estimates near $1.46, with backlog now at $1.2 billion. A beat that size forces analysts to raise their full year numbers, not write it off as one good quarter.

Constellation Brands $STZ ( ▼ 4.54% )  

Reports before the bell, the first major consumer name this quarter. Weak beer and spirits volumes would force traders to question whether the hot economy is finally cooling at the checkout.

Reports after the close near its lowest level in eleven years. Holders are forced to pick if bottom worth buying, or a turnaround that keeps slipping, and the read is in whether demand stabilized, not the headline.

Digital Realty $DLR ( ▼ 1.25% )  

Down in premarket after agreeing to buy a stake in three Northern Virginia data centers from Blackstone for $7.8 billion. It's paying $2.3 billion of that in stock, so existing holders are getting diluted as the company expands, and they have to decide if the scale is worth it.

Slipped after a House committee opened a probe into their China drug trials and possible military ties. Merck has run 224 trials there since 2005 and AbbVie over 100 since 2007, so both are forced to respond before this becomes a lasting overhang.

Strategy $MSTR ( ▲ 12.6% )  

Lower premarket, giving back part of Monday's run after it dropped its pledge to never sell bitcoin. Anyone holding it as a pure bitcoin proxy is forced to reprice the premium, because a company that might sell its coins is worth less than one that never will.

What to Watch

IPO’s

MarketBeat did an excellent job on this free IPO guide on IPO’s happening this year.

Quarter-End Rebalancing, Into The Close
After a quarter where chips ran far ahead and big tech fell, funds that rebalance to fixed weights have to sell winners and buy laggards today. That mechanical flow can push against the trend in the final hour, so a quiet tape can turn choppy near 4 PM. Don't read too much into a late reversal.

Medicare Obesity Coverage, Tomorrow
Starting July 1, Medicare covers obesity drugs for the first time, opening a large new patient pool for Novo Nordisk and Eli Lilly. Almost no one is positioning for it, and it's a real demand catalyst for the GLP-1 makers heading into their next prints.


- John

Note: This newsletter is intended for informational purposes only. This edition is in partnership with MarketBeat.